Diabetes Education News

Bayer announced positive top-line results for the FINEARTS-HF trial of finerenone, in which the drug reduced risk for cardiovascular death and heart failure events in patients with HF with preserved or mildly reduced ejection fraction.

Quality testing of three counterfeit semaglutide products found low purity and more measured semaglutide than what was on the label, according to a research letter published in JAMA Network Open.

The number of monthly prescription fills for semaglutide increased by 442% from 2021 to 2023, according to a research letter published in JAMA Health Forum.

Adults using a GLP-1 receptor agonist do not have increased risk for nonarteritic anterior ischemic optic neuropathy, according to data from a retrospective analysis published in Journal of Diabetes Science and Technology.

Individuals with type 2 diabetes who received semaglutide had lower probability for medical care related to tobacco dependence compared with other antidiabetes medications, the results of a study in the Annals of Internal Medicine showed.

NEW ORLEANS — In part three of a three-part video exclusive series, Jonathan D. Leffert, MD, talks with Kimber Simmons, MD, MS, about how providers should discuss treatments for people with early-stage type 1 diabetes.

NEW ORLEANS — In part two of a three-part video exclusive series, Jonathan D. Leffert, MD, talks with Rifka C. Schulman-Rosenbaum, MD, FACE, FACP, about the steps providers should take when a patient screens positive for type 1 diabetes.

NEW ORLEANS — In part one of a three-part video exclusive series, Jonathan D. Leffert, MD, talks with Anna Casu, MD, about the preclinical stages of type 1 diabetes and who should be screened for the disease.

The FDA granted breakthrough device designation for an endoscopic procedure that resurfaces the duodenum lining to allow for weight maintenance after discontinuation of a GLP-1 receptor agonist, according to an industry press release.

The presence of thyroid autoantibodies may be detected as early as age 10 months for children, and those positive for both thyroid peroxidase and thyroglobulin autoantibodies have a higher risk for thyroid disease, according to study data.